"Adiponectin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A 30-kDa COMPLEMENT C1Q-related protein, the most abundant gene product secreted by FAT CELLS of the white ADIPOSE TISSUE. Adiponectin modulates several physiological processes, such as metabolism of GLUCOSE and FATTY ACIDS, and immune responses. Decreased plasma adiponectin levels are associated with INSULIN RESISTANCE; TYPE 2 DIABETES MELLITUS; OBESITY; and ATHEROSCLEROSIS.
| Descriptor ID |
D052242
|
| MeSH Number(s) |
D06.472.699.042.249 D12.644.276.024.249 D12.644.548.011.249 D12.776.467.024.249 D23.529.024.249
|
| Concept/Terms |
Adiponectin- Adiponectin
- Adipocyte Complement-Related Protein 30-kDa
- Adipocyte Complement Related Protein 30 kDa
- Adipose Most Abundant Gene Transcript 1
- apM-1 Protein
- apM 1 Protein
- ACRP30 Protein
- Adipocyte, C1q and Collagen Domain Containing Protein
|
Below are MeSH descriptors whose meaning is more general than "Adiponectin".
Below are MeSH descriptors whose meaning is more specific than "Adiponectin".
This graph shows the total number of publications written about "Adiponectin" by people in this website by year, and whether "Adiponectin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 2 | 2 |
| 2010 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 21 | 9 | 30 |
| 2018 | 14 | 3 | 17 |
| 2019 | 3 | 6 | 9 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Adiponectin" by people in Profiles.
-
Adiponectin to leptin ratio reflects inflammatory burden and survival in COVID-19. Diabetes Metab. 2021 11; 47(6):101268.
-
Are adipokines the missing link between obesity, immune response, and outcomes in severe COVID-19? Int J Obes (Lond). 2021 09; 45(9):2126-2131.
-
Reduced adiponectin levels in patients with COVID-19 acute respiratory failure: A case-control study. Physiol Rep. 2021 04; 9(7):e14843.
-
Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2. Drug Discov Today. 2021 08; 26(8):2036-2044.
-
Functional Role of Dietary Intervention to Improve the Outcome of COVID-19: A Hypothesis of Work. Int J Mol Sci. 2020 Apr 28; 21(9).
-
Effects of Adiponectin on Diastolic Function in Mice Underwent Transverse Aorta Constriction. J Cardiovasc Transl Res. 2020 04; 13(2):225-237.
-
A negative screening of rare genetic variants in the ADIPOQ and STATH genes in cystic fibrosis. Pulmonology. 2020 May - Jun; 26(3):138-144.
-
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study. Cardiovasc Diabetol. 2019 03 04; 18(1):24.
-
The role of adipokines in systemic sclerosis: a missing link? Arch Dermatol Res. 2019 May; 311(4):251-263.
-
Pulmonary Hypertension and Obesity: Focus on Adiponectin. Int J Mol Sci. 2019 Feb 20; 20(4).